WPP Investors Have Opportunity to Join WPP plc Fraud Investigation with the Schall Law Firm
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. WPP disclosed on July 8, 2025, that it was 'reducing our guidance for 2025 [like-for-like] revenue less pass-through costs to -3% to -5% and now expect a year-on-year decline in headline operating profit margin of 50 to 175 bps (excluding FX) reflecting benefits from continued action on costs.' The Company added that 'Against a challenging economic backdrop, we have seen a deterioration in performance as Q2 has progressed' and that 'continued macro uncertainty weighing on client spend and weaker net new business than originally anticipated.' Based on this news, WPP's ADRs fell by more than 18% on the same day.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
TransDigm Group (NYSE:TDG) Could Become A Multi-Bagger
To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed. Put simply, these types of businesses are compounding machines, meaning they are continually reinvesting their earnings at ever-higher rates of return. With that in mind, the ROCE of TransDigm Group (NYSE:TDG) looks great, so lets see what the trend can tell us. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Return On Capital Employed (ROCE): What Is It? For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for TransDigm Group, this is the formula: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.20 = US$3.9b ÷ (US$22b - US$2.1b) (Based on the trailing twelve months to March 2025). So, TransDigm Group has an ROCE of 20%. In absolute terms that's a great return and it's even better than the Aerospace & Defense industry average of 11%. View our latest analysis for TransDigm Group In the above chart we have measured TransDigm Group's prior ROCE against its prior performance, but the future is arguably more important. If you're interested, you can view the analysts predictions in our free analyst report for TransDigm Group . The Trend Of ROCE The trends we've noticed at TransDigm Group are quite reassuring. The data shows that returns on capital have increased substantially over the last five years to 20%. The amount of capital employed has increased too, by 32%. This can indicate that there's plenty of opportunities to invest capital internally and at ever higher rates, a combination that's common among multi-baggers. In Conclusion... To sum it up, TransDigm Group has proven it can reinvest in the business and generate higher returns on that capital employed, which is terrific. And with the stock having performed exceptionally well over the last five years, these patterns are being accounted for by investors. With that being said, we still think the promising fundamentals mean the company deserves some further due diligence. If you'd like to know more about TransDigm Group, we've spotted 3 warning signs, and 2 of them are a bit concerning. If you want to search for more stocks that have been earning high returns, check out this free list of stocks with solid balance sheets that are also earning high returns on equity. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29 minutes ago
- Yahoo
The one-year underlying earnings growth at Merck (NYSE:MRK) is promising, but the shareholders are still in the red over that time
Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that vastly outperform the market - but in the process, they risk under-performance. That downside risk was realized by Merck & Co., Inc. (NYSE:MRK) shareholders over the last year, as the share price declined 31%. That's disappointing when you consider the market returned 19%. Longer term shareholders haven't suffered as badly, since the stock is down a comparatively less painful 9.3% in three years. The last week also saw the share price slip down another 6.4%. This could be related to the recent financial results - you can catch up on the most recent data by reading our company report. Since Merck has shed US$14b from its value in the past 7 days, let's see if the longer term decline has been driven by the business' economics. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. Even though the Merck share price is down over the year, its EPS actually improved. It could be that the share price was previously over-hyped. The divergence between the EPS and the share price is quite notable, during the year. But we might find some different metrics explain the share price movements better. Merck's dividend seems healthy to us, so we doubt that the yield is a concern for the market. The revenue trend doesn't seem to explain why the share price is down. Of course, it could simply be that it simply fell short of the market consensus expectations. The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail). We like that insiders have been buying shares in the last twelve months. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. You can see what analysts are predicting for Merck in this interactive graph of future profit estimates. What About Dividends? As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. As it happens, Merck's TSR for the last 1 year was -29%, which exceeds the share price return mentioned earlier. The dividends paid by the company have thusly boosted the total shareholder return. A Different Perspective While the broader market gained around 19% in the last year, Merck shareholders lost 29% (even including dividends). However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. On the bright side, long term shareholders have made money, with a gain of 4% per year over half a decade. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - Merck has 1 warning sign we think you should be aware of. Merck is not the only stock that insiders are buying. For those who like to find lesser know companies this free list of growing companies with recent insider purchasing, could be just the ticket. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
31 minutes ago
- Forbes
Buy or Sell SNAP Stock Ahead of Its Results?
Snap (NYSE:SNAP) is set to disclose its earnings on Tuesday, August 5, 2025. Throughout the last five years, Snap's stock has often responded unfavorably to earnings announcements. In 61% of cases, the stock has experienced a negative one-day return following the results. The median one-day decrease has been a noteworthy -17.0%, with a peak one-day fall of -39.1%. For traders focused on events, recognizing these historical trends can be beneficial; however, the actual outcomes compared to consensus and expectations will be critical. There are two primary strategies to keep in mind: Analysts expect Snap to declare earnings of $0.02 per share alongside sales of $1.35 billion. This is compared to earnings of $0.02 per share with sales of $1.24 billion in the same quarter from the previous year. At present, Snap has a market capitalization of $16 billion. Over the past twelve months, the company generated $5.5 billion in revenue. However, the company was operationally unprofitable, recording $-648 million in operating losses and a net loss of $-532 million. Nonetheless, if you are looking for potential gains with lower volatility than individual stocks, the Trefis High Quality portfolio offers an alternative — it has surpassed the S&P 500 and achieved returns exceeding 91% since its inception. View earnings reaction history of all stocks Snap's Historical Likelihood of Positive Post-Earnings Returns Some insights regarding one-day (1D) returns following earnings: Additional data for observed 5-Day (5D) and 21-Day (21D) returns after earnings are outlined along with the statistics in the table below. Relationship Between 1D, 5D, and 21D Historical Returns A relatively lower-risk approach (though ineffective if the correlation is minimal) involves understanding the connection between short-term and medium-term returns following earnings, identifying a pair with the strongest correlation, and executing the suitable trade. For instance, if 1D and 5D exhibit the highest correlation, a trader can take a 'long' position for the subsequent 5 days if the 1D post-earnings return is positive. Below is some correlation data derived from a 5-year and a more recent 3-year history. Please note that the correlation 1D_5D indicates the relationship between 1D post-earnings returns and the consequent 5D returns. Does Peer Earnings Correlate? Occasionally, peer performance can affect the stock's response post-earnings. Indeed, the market may start to price in effects before the earnings are announced. Here is some historical data reflecting the past post-earnings performance of Snap stock compared with the stock performance of peers that disclosed earnings immediately before Snap. For accurate comparison, peer stock returns also denote post-earnings one-day (1D) returns. Discover more about Trefis RV strategy that has outperformed its all-cap stocks benchmark (a combination of all three: the S&P 500, S&P mid-cap, and Russell 2000), producing excellent returns for investors. Additionally, if you are interested in potential gains with a smoother experience than an individual stock like Snap, consider the High Quality portfolio, which has surpassed the S&P and achieved >91% returns since its inception.
